4.8 Article

Chromogranin B P413L variant as risk factor and modifier of disease onset for amyotrophic lateral sclerosis

Related references

Note: Only part of the references are listed.
Article Endocrinology & Metabolism

Chromogranin peptides in amyotrophic lateral sclerosis

A. Schrott-Fischer et al.

REGULATORY PEPTIDES (2009)

Article Biochemistry & Molecular Biology

Wild-type superoxide dismutase acquires binding and toxic properties of ALS-linked mutant forms through oxidation

Samer Abou Ezzi et al.

JOURNAL OF NEUROCHEMISTRY (2007)

Article Biochemistry & Molecular Biology

Sequence-based prediction of pathological mutations

C Ferrer-Costa et al.

PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2004)

Article Biochemistry & Molecular Biology

Prediction of deleterious human alleles

S Sunyaev et al.

HUMAN MOLECULAR GENETICS (2001)

Article Clinical Neurology

El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis

BR Brooks et al.

AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS (2000)